136 related articles for article (PubMed ID: 31400708)
21. p53-dependent inhibition of TrxR1 contributes to the tumor-specific induction of apoptosis by RITA.
Hedström E; Eriksson S; Zawacka-Pankau J; Arnér ES; Selivanova G
Cell Cycle; 2009 Nov; 8(21):3584-91. PubMed ID: 19838062
[TBL] [Abstract][Full Text] [Related]
22. Exploration of 3,4-unsubstituted coumarins as thioredoxin reductase 1 inhibitors for cancer therapy.
Nikitjuka A; Ozola M; Jackevica L; Bobrovs R; Žalubovskis R
Org Biomol Chem; 2023 Dec; 21(48):9630-9639. PubMed ID: 38018884
[TBL] [Abstract][Full Text] [Related]
23. Potent inhibition of gastric cancer cells by a natural compound via inhibiting TrxR1 activity and activating ROS-mediated p38 MAPK pathway.
He W; Cao P; Xia Y; Hong L; Zhang T; Shen X; Zheng P; Shen H; Zhao Y; Zou P
Free Radic Res; 2019 Jan; 53(1):104-114. PubMed ID: 30668191
[TBL] [Abstract][Full Text] [Related]
24. Targeting Thioredoxin Reductase by Parthenolide Contributes to Inducing Apoptosis of HeLa Cells.
Duan D; Zhang J; Yao J; Liu Y; Fang J
J Biol Chem; 2016 May; 291(19):10021-31. PubMed ID: 27002142
[TBL] [Abstract][Full Text] [Related]
25. Acetylation Regulates Thioredoxin Reductase Oligomerization and Activity.
Wright DE; Altaany Z; Bi Y; Alperstein Z; O'Donoghue P
Antioxid Redox Signal; 2018 Aug; 29(4):377-388. PubMed ID: 29117711
[TBL] [Abstract][Full Text] [Related]
26. Irreversible TrxR1 inhibitors block STAT3 activity and induce cancer cell death.
Busker S; Qian W; Haraldsson M; Espinosa B; Johansson L; Attarha S; Kolosenko I; Liu J; Dagnell M; Grandér D; Arnér ESJ; Tamm KP; Page BDG
Sci Adv; 2020 Mar; 6(12):eaax7945. PubMed ID: 32219156
[TBL] [Abstract][Full Text] [Related]
27. Combinatorial synthesis, in silico, molecular and biochemical studies of tetrazole-derived organic selenides with increased selectivity against hepatocellular carcinoma.
Shaaban S; Negm A; Ashmawy AM; Ahmed DM; Wessjohann LA
Eur J Med Chem; 2016 Oct; 122():55-71. PubMed ID: 27343853
[TBL] [Abstract][Full Text] [Related]
28. APR-246/PRIMA-1MET inhibits thioredoxin reductase 1 and converts the enzyme to a dedicated NADPH oxidase.
Peng X; Zhang MQ; Conserva F; Hosny G; Selivanova G; Bykov VJ; Arnér ES; Wiman KG
Cell Death Dis; 2013 Oct; 4(10):e881. PubMed ID: 24157875
[TBL] [Abstract][Full Text] [Related]
29. Selective killing of gastric cancer cells by a small molecule via targeting TrxR1 and ROS-mediated ER stress activation.
Chen W; Zou P; Zhao Z; Weng Q; Chen X; Ying S; Ye Q; Wang Z; Ji J; Liang G
Oncotarget; 2016 Mar; 7(13):16593-609. PubMed ID: 26919094
[TBL] [Abstract][Full Text] [Related]
30. Targeting the Selenoprotein Thioredoxin Reductase 1 for Anticancer Therapy.
Arnér ESJ
Adv Cancer Res; 2017; 136():139-151. PubMed ID: 29054416
[TBL] [Abstract][Full Text] [Related]
31. Inhibition and crosslinking of the selenoprotein thioredoxin reductase-1 by p-benzoquinone.
Shu N; Cheng Q; Arnér ESJ; Davies MJ
Redox Biol; 2020 Jan; 28():101335. PubMed ID: 31590044
[TBL] [Abstract][Full Text] [Related]
32. Activity of rat cytosolic thioredoxin reductase is strongly decreased by trans-[bis(2-amino-5- methylthiazole)tetrachlororuthenate(III)]: first report of relevant thioredoxin reductase inhibition for a ruthenium compound.
Mura P; Camalli M; Bindoli A; Sorrentino F; Casini A; Gabbiani C; Corsini M; Zanello P; Rigobello MP; Messori L
J Med Chem; 2007 Nov; 50(24):5871-4. PubMed ID: 17975904
[TBL] [Abstract][Full Text] [Related]
33. [Selenoprotein thioredoxin reductase mediated menadione reduction: catalytic properties & inhibition effects].
Zhang N; Sun S; Zhang Y; Yang Y; Zhang Y; Chen J; Xu W; Ma Q; Xu J
Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):2139-2150. PubMed ID: 33169578
[TBL] [Abstract][Full Text] [Related]
34. Treatment of lung cancer cells with cytotoxic levels of sodium selenite: effects on the thioredoxin system.
Selenius M; Fernandes AP; Brodin O; Björnstedt M; Rundlöf AK
Biochem Pharmacol; 2008 Jun; 75(11):2092-9. PubMed ID: 18405881
[TBL] [Abstract][Full Text] [Related]
35. Selenocysteine induces apoptosis in human glioma cells: evidence for TrxR1-targeted inhibition and signaling crosstalk.
Fan CD; Fu XY; Zhang ZY; Cao MZ; Sun JY; Yang MF; Fu XT; Zhao SJ; Shao LR; Zhang HF; Yang XY; Sun BL
Sci Rep; 2017 Jul; 7(1):6465. PubMed ID: 28743999
[TBL] [Abstract][Full Text] [Related]
36. The Cellular Thioredoxin-1/Thioredoxin Reductase-1 Driven Oxidoreduction Represents a Chemotherapeutic Target for HIV-1 Entry Inhibition.
Reiser K; Mathys L; Curbo S; Pannecouque C; Noppen S; Liekens S; Engman L; Lundberg M; Balzarini J; Karlsson A
PLoS One; 2016; 11(1):e0147773. PubMed ID: 26816344
[TBL] [Abstract][Full Text] [Related]
37. Mitochondrial thioredoxin reductase inhibition, selenium status, and Nrf-2 activation are determinant factors modulating the toxicity of mercury compounds.
Branco V; Godinho-Santos A; Gonçalves J; Lu J; Holmgren A; Carvalho C
Free Radic Biol Med; 2014 Aug; 73():95-105. PubMed ID: 24816296
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of N-acetyl-S-(p-chlorophenylcarbamoyl)cysteine as an irreversible inhibitor of mammalian thioredoxin reductase1.
Chen W; Jiang Z; Lin N; Zheng Z; Chen Z; Zhang X; Guan X
J Enzyme Inhib Med Chem; 2016; 31(2):229-35. PubMed ID: 25778746
[TBL] [Abstract][Full Text] [Related]
39. Simvastatin inhibits the core promoter of the TXNRD1 gene and lowers cellular TrxR activity in HepG2 cells.
Ekström L; Johansson M; Monostory K; Rundlöf AK; Arnér ES; Björkhem-Bergman L
Biochem Biophys Res Commun; 2013 Jan; 430(1):90-4. PubMed ID: 23154180
[TBL] [Abstract][Full Text] [Related]
40. Thiophosphate and selenite conversely modulate cell death induced by glutathione depletion or cisplatin: effects related to activity and Sec contents of thioredoxin reductase.
Peng X; Xu J; Arnér ES
Biochem J; 2012 Oct; 447(1):167-74. PubMed ID: 22784015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
